A R T I C L E I N F O
Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous toothderived pulp stem cells of children with autism spectrum disorder ASD exists as a spectrum, and has highly heterogeneous variants.
In silico analysis suggests that various genes associated with the dopaminergic pathway contribute to the pathogenesis of ASD, supporting experimental evidences and the dopamine hypothesis [5, 6] . On the other hand, mitochondrial dysfunction has been reported in the analysis of various tissues and postmortem brains of patients with ASD [7, 8] . However, only a few studies focusing on the neuropathological association between dopaminergic neurons (DN) and mitochondria in ASD have been conducted, since the direct examination of neurons in vivo is invasive and restricted.
Stem cells from human exfoliated deciduous teeth (SHED) are neural crest-derived mesenchymal multipotent stem cells obtained from the dental pulp of exfoliated deciduous teeth [9] . Some groups have succeeded in differentiating SHED into DN in vitro [10, 11] . The earliest age for spontaneous exfoliation of deciduous teeth in humans is approximately 6 years [12] . This age corresponds to the early stage of ASD, when it is important to determine the optimal treatment strategies for children suspected to have, or those diagnosed with, ASD [13] [14] [15] .
The purpose of this study was to clarify the pathological association between development of DN and mitochondria in ASD by using SHED as a disease-or patient-specific cellular model for neurobiological analysis. For this purpose, we obtained SHED from three children with ASD, and examined the neurobiological features of DN differentiated from the SHED, comparing them with those differentiated from SHED shown. ***P < 0.001. DN, Dopaminergic neurons; ASD, Autism spectrum disorder; TH, tyrosine hydroxylase; Ctrl-DNs, DN differentiated from stem cells derived from exfoliated deciduous teeth of typically developing children; ASD-DNs, DN differentiated from stem cells derived from exfoliated deciduous teeth of children with ASD; DAPI, 4ˊ,6-diamidino-2-phenylindole dihydrochloride; SEM, standard error of the mean; n.s., not significant.
obtained from three typically developing children.
Materials and methods

Isolation and culture of SHED
Experiments using human samples were reviewed and approved by the Kyushu University Institutional Review Board for Human Genome/ Gene Research (permission number: 678-00), and were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from the patients' guardians. Deciduous teeth were collected from three typically developing children (4, 6, and 7 years old, respectively) and three children with ASD (5, 6, and 7 years old, respectively). None of these 3 ASD children showed comorbidities with chromosomal defects, epilepsy or syndromic phenotypes of tuberous sclerosis, Rett syndrome and other Mendelian disorders. The SHED were isolated as previously described [16] , and were cultured in Alpha Modification of Eagle's Medium (Sigma-Aldrich, MO, USA) containing 15% fetal bovine serum (Sigma-Aldrich), 100 µM L-ascorbic acid 2-phosphate (Wako Pure Chemical Industries, Osaka, Japan), 2 mM Lglutamine (Life Technologies, NY, USA), 250 µg/mL fungizone (Life Technologies), 100 U/mL penicillin, and 100 µg/mL streptomycin (Life Technologies), at 37°C, in an atmosphere containing 5% CO 2 . The cells were used for further experiments as a heterogeneous cell population, according to the experimental procedures reported by previous studies [9] [10] [11] .
Differentiation of SHED into DN
Differentiation of SHED into DN was induced as described previously [11] , but with minor modifications (brain derived neurotrophic factor [BDNF] was excluded except for the experiments shown in Fig. 5 ). In the first step, 1.5 × 10 5 SHED were plated in a 6-well culture plate, in the culture medium described above, and incubated overnight at 37°C, in an atmosphere containing 5% CO 2 , and were then cultured in serum-free Dulbecco's Modified Eagle's Medium (DMEM, Sigma-Aldrich) supplemented with 20 ng/mL epidermal growth factor (SigmaAldrich), 20 ng/mL basic fibroblast growth factor (Peprotech, NJ, USA), and 1% N2 supplement (Life Technologies) for 2 days, at 37°C, in an atmosphere containing 5% CO 2 . In the second step, DMEM was replaced with neurobasal medium (Life Technologies) supplemented with 2% B27 supplement (Life Technologies), 1 mM dibutyryladenosine 3,5-cyclic monophosphate (Sigma-Aldrich), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), and 200 μM ascorbic acid (Nacalai Tesque, Kyoto, Japan), and cells were incubated for 5 days, at 37°C, in an atmosphere containing 5% CO 2 . During the second step, no supplementing factors were added. In the experiment shown in Fig. 5 , the differentiation of SHED was performed in the presence or absence of 50 ng/mL BDNF in the second step.
Immunocytochemistry
The SHED cultured on a cover glass were fixed with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS, pH 7.4) for 10 min, and were subsequently permeabilized with 0.1% Triton X-100 for 5 min. The cells were blocked with 2% bovine serum albumin in PBS for 20 min. Following this, the cells were incubated with one of the following primary antibodies, for 90 min: anti-Tom20 (Santa Cruz Biotechnology, CA, USA), anti-tyrosine hydroxylase (TH; Proteintech, IL, USA), anti-β-Tubulin III (Sigma-Aldrich). The cells were subsequently incubated with Alexa Fluor-conjugated secondary antibodies (Life Technologies). After staining with secondary antibodies in the dark for 60 min, the nuclei were counterstained with 4ˊ,6-diamidino-2-phenylindole dihydrochloride (DAPI; Dojindo, Kumamoto, Japan). The cover glasses were then mounted on slides, using the ProLong Diamond mounting medium (Life Technologies).
Analysis of neurite outgrowth and branching in cultured DN
Fluorescence images of DN stained with TH and DAPI were acquired using a Nikon C2 confocal microscope (Nikon, Tokyo, Japan), followed by measurement of the maximum length and total number of neurite branches of each double-positive cell. This measurement was performed using the Neurite Outgrowth module of the MetaMorph software (Molecular Devices, CA, USA) [17] .
Measurement of Tom20-stained area per cell area
Fluorescence images of DN stained with Tom20, TH, and DAPI were acquired using a Nikon C2 confocal microscope (Nikon). The Tom20-stained and TH-stained area of each DN were measured as the mitochondrial and cell area, respectively. The measurement of each area was performed using the Multi Wavelengths Cell Scoring module of the MetaMorph software (Molecular Devices).
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was measured by staining with JC-1 (Life Technologies), as previously described [16] . Populations of 10,000 cells were analyzed for each sample, and green and red JC-1 signals were detected using the FL1 and FL2 channels, respectively, of a FACSCalibur (BD Bioscience, CA, USA) flow cytometer. The geometric means of FL1 and FL2 were measured using the CellQuest software (BD Bioscience), and the FL2/FL1 ratio was calculated. A higher FL2/FL1 ratio implied high MMP.
Analysis of intracellular ATP levels
The cells were harvested in ice-cold PBS. To measure intracellular ATP levels, CellTiter-Glo Luminescent Cell Viability Assay (Promega, WI, USA) was used. The ATP luminescence signals were divided by the number of cells.
Measurement of intracellular calcium levels
In order to measure intracellular calcium (Ca 2+ ) levels, the cells were cultured in µ-dishes (ibidi, Munich, Germany), and then incubated with 2 µM Fluo-4 AM (Life Technologies), 0.05% (w/v) Pluronic F-127 (Sigma-Aldrich), and 500 µM probenecid (Sigma-Aldrich) in Hanks' Balanced Salt Solution for 1 h, at 37°C. Fluorescent images of Fluo-4 signal were acquired using a Nikon C2 confocal microscope (Nikon). The fluorescence intensity of Fluo-4 per area, for each cell, was measured using the NIS-Elements software (Nikon).
Quantitative reverse transcription polymerase chain reaction (RTqPCR)
The expression of transcription factors that are involved in the specification of the midbrain dopaminergic lineage, pituitary homeobox 3 (PITX3) [18, 19] , and nuclear receptor related 1 protein (NURR1) [20, 21] were measured using RT-qPCR. Total RNA extraction and RT-qPCR were performed as previously described [16] . The sequences of the primer sets used in this study were as follows: PITX3, 5′-CCTACGAGGAGGTGTACCCC-3′ (forward) and 5′-AGGCGAATGGAA AGGTCTTGG-3′ (reverse); NURR1, 5′-GCACTTCGGCAGAGTTGAA TGA-3′ (forward) and 5′-GGTGGCTGTGTTGCTGGTAGTT-3′ (reverse); and GAPDH, 5′-GCACCGTCAAGGCTGAGAAC-3′ (forward) and 5′-ATG GTGGTGAAGACGCCAGT-3′ (reverse). The relative expression levels of the target genes were analyzed using the comparative threshold cycle method by normalizing them to GAPDH expression levels.
Statistical analyses
Statistical analyses were performed with the Student's t-test, using SPSS software version 20 (IBM, IL, USA). Values are presented as means ± standard error of the mean (SEM). P < 0.05 was considered statistically significant.
Results
Neurite development of DN differentiated from SHED derived from children with ASD
All SHED derived from the three typically developing children and those derived from the three children with ASD were differentiated into cells positive for TH, a DN marker, after being subjected to the differentiation-induction procedure without BDNF (Fig. 1A) . There was no significant difference between these two groups in the mRNA expression levels of other midbrain DN markers, PITX3 and NURR1, as well as the ratio of TH-positive cells after differentiation (Fig. 1B and C) . However, the maximum neurite length and total number of branches per cell were lower for DN differentiated from SHED derived from children with ASD (ASD-DNs) than for those from the typically developing children (Ctrl-DNs) (Fig. 1A) ; quantitative analysis showed that this difference was statistically significant (Fig. 1D and E) . These data suggest that SHED derived from children with ASD may differentiate into DN, but may not achieve adequate neurite development. shown. ***P < 0.001. ASD-DNs, Dopaminergic neurons differentiated from stem cells derived from exfoliated deciduous teeth of children with autism spectrum disorder; Ctrl-DNs, Dopaminergic neurons differentiated from stem cells derived from exfoliated deciduous teeth of typically developing children; SEM, standard error of the mean.
Decreased mitochondrial activity and distribution within neurites of ASD-DNs
Neurite development requires large amounts of ATP, mainly supplied by mitochondria. The MMP and ATP production were measured to examine the association between mitochondrial activity and inadequate neurite development in ASD-DNs. Both MMP and ATP levels were significantly lower in ASD-DNs than in Ctrl-DNs ( Fig. 2A and B) . Neurite development is closely related to mitochondrial recruitment [22] . Thus, we next examined mitochondrial distribution within neurites (Fig. 3A  and B) . Quantitative analysis showed that the percentage of mitochondria-containing neurites was significantly lower in ASD-DNs than in Ctrl-DNs (Fig. 3C) . Tom20-stained area per cell area was significantly lower in ASD-DNs than in Ctrl-DNs (Fig. 3D) . These results suggest that the impaired neurite development observed in ASD-DNs is associated with decreased mitochondrial activity and distribution within neurites as well as decreased amount of mitochondria within cells.
Decreased intracellular calcium levels in ASD-DNs
Calcium plays an important role in neurite development [23] . Calcium metabolism and homeostasis are important mitochondrial functions. The amount of intracellular Ca 2+ was significantly lower in ASD- DNs than in Ctrl-DNs (Fig. 4A-D) . This suggests that decreased neurite development in ASD-DNs is associated with decreased mitochondriamediated Ca 2+ metabolism.
Effect of BDNF on neurite outgrowth and branching in ASD-DNs
It is known that BDNF promotes neurite outgrowth and branching during neuronal development. We tested whether the decreased neurite development of ASD-DNs observed in the BDNF-free protocol improved upon BDNF supplementation (Fig. 5A-C) . Consistent with previous reports, BDNF supplementation was effective in producing maximum neurite outgrowth and total number of branches per cell in Ctrl-DNs. However, no apparent effects of BDNF were observed in ASD-DNs, suggesting impairment of the signaling pathway downstream of BDNF involved in neurite outgrowth and branching.
Discussion
In the present study, we differentiated SHED into DN using an induction medium modified from the technique suggested by Fujii et al. [11] ; BDNF was not supplemented in our medium, except for the experiment shown in Fig. 5 . It is known that BDNF promotes neuronal maturation by autocrine or paracrine mechanisms, impairments in BDNF signaling are involved in the neuropathogenesis of Rett syndrome which involves autistic symptoms [24] [25] [26] . Therefore, a BDNF-supplemented medium may mask the impairment of these mechanisms. We found that the SHED derived from the three children with ASD tested in this study could differentiate into DN without BDNF, but the neurite development was impaired after differentiation, and this was associated with mitochondrial dysfunction, including decreased MMP, ATP levels, mitochondrial transport, and Ca 2+ levels. In addition, supplementation of BDNF did not ameliorate the impaired neurite development of ASDDNs. Neurite development involves ATP-dependent morphological and functional alterations, such as cell membrane enlargement, cytoskeletal rearrangement, and transport of various substances to the neurite terminals [27] . Therefore, it is important to recruit active mitochondria to the neurite growth cones. The decreased MMP observed in ASD-DNs in this study may have resulted in an insufficient ATP production for neurite development as well as unsuccessful recruitment of mitochondria to the neurites. Kinesin, a motor protein, plays an important role in the recruitment of mitochondria from the cell body to the neurites [28] ; Miro1 is one of the factors that binds mitochondria to kinesin, and this binding is inhibited by decreased MMP levels [29] . In addition, the decreased amount of mitochondria in ASD-DNs may also have been involved in the insufficient ATP supply, although the mechanism was not clarified here.
In this study, the intracellular Ca 2+ concentration in the ASD-DNs was decreased, suggesting the role of mitochondrial dysfunction in Ca 2+ deregulation. Intracellular Ca 2+ plays important roles in the regulation of signaling molecules, such as Ca 2+ /calmodulin-dependent protein kinases (CaMKs), for neuronal development and function [23] .
In primary cultures of rat cortical neurons, it has been shown that BDNF-induced neurite outgrowth is promoted by CaMKIIβ-mediated LIM kinase 1 activation [30] . It is likely, therefore, that reduction of intracellular Ca 2+ may attenuate neurite development via the BDNFCaMKIIβ-LIM kinase 1 pathway. This may be supported by our observation that supplementation of BDNF did not show any effect on neurite development of ASD-DNs. In addition, BDNF activates the mitochondrial respiratory complex I and promotes mitochondrial biogenesis via peroxisome proliferator-activated receptor gamma coactivator 1-alpha, suggesting that the interaction between BDNF and mitochondrial function may be involved in neurite development [31, 32] . In this study, there are several limitations to understanding the underlying neuropathology of ASD. First, the neurobiological characteristics of ASD-DNs that we described here do not necessarily reflect the activity and function of DN of the patients we tested. In the brain, the growth and function of DN is modified by interaction with other types of neurons or glial cells [33] . Second, it is impossible to generalize the impaired neurite development of DN to the whole ASD population because ASD shows a broad spectrum, including highly heterogeneous genetic backgrounds. Third, it is not clear whether mitochondrial dysfunction is primary, due to mutations of the genes that directly regulate the function, or secondary, due to the other genetic or functional defects, such as impaired BDNF signaling. To address these concerns, further studies are required, involving co-culture of SHED with other types of cells, more number of subjects, and mutation analysis of mitochondrial and nuclear genes.
In conclusion, we demonstrate that DN differentiated from SHED from children with ASD show impaired neurite development, associated with mitochondrial dysfunction. These results suggest that intracerebral dopamine production may have decreased in these patients. Such findings may, thus, contribute to the development of optimal individualized therapeutic strategies for the treatment of patients in the early stages of ASD.
